chr11-72825332-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033388.2(ATG16L2):āc.1027C>Gā(p.Arg343Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000351 in 1,613,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033388.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATG16L2 | NM_033388.2 | c.1027C>G | p.Arg343Gly | missense_variant | 10/18 | ENST00000321297.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATG16L2 | ENST00000321297.10 | c.1027C>G | p.Arg343Gly | missense_variant | 10/18 | 1 | NM_033388.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000295 AC: 74AN: 250900Hom.: 0 AF XY: 0.000324 AC XY: 44AN XY: 135618
GnomAD4 exome AF: 0.000366 AC: 535AN: 1461368Hom.: 0 Cov.: 31 AF XY: 0.000414 AC XY: 301AN XY: 726968
GnomAD4 genome AF: 0.000204 AC: 31AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2023 | The c.1027C>G (p.R343G) alteration is located in exon 10 (coding exon 10) of the ATG16L2 gene. This alteration results from a C to G substitution at nucleotide position 1027, causing the arginine (R) at amino acid position 343 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at